We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 154.21 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTTM TIDM0Y7T
RNS Number : 3214M
Northern Trust Corporation
13 September 2019
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing Northern Trust Corporation (Note 1) Company dealt in Allergan PLC =========================== Class of relevant security Common Stock USD 0.0033 to which the dealings being disclosed relate (Note 2) =========================== Date of dealing 12(th) September 2019 =========================== 2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short Number (%) Number (%) ========== ====== =========== ====== (1) Relevant securities 3,703,490 1.13% ================== =================== (2) Derivatives (other than options) ================== =================== (3) Options and agreements to purchase/sell ================== =================== Total 3,703,490 1.13% ================== ===================
* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 205 securities into the relevant accounts.
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short Number (%) Number (%) ========= ====== =========== ====== (1) Relevant securities =================== ===================== (2) Derivatives (other than options) =================== ===================== (3) Options and agreements to purchase/sell =================== ===================== Total =================== =====================
Ap20
1. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant Price per unit ($) securities BUY 170 166.39 =========================== ======================== BUY 30 166.35 =========================== ======================== BUY 29 166.68 =========================== ======================== SELL 9 166.35 =========================== ======================== BUY 15 166.35 =========================== ======================== BUY 519 166.94 =========================== ======================== BUY 10 166.35 =========================== ======================== BUY 5 166.35 =========================== ======================== BUY 249 166.68 =========================== ======================== BUY 1 166.35 =========================== ======================== BUY 48 166.35 =========================== ======================== BUY 2 166.68 =========================== ======================== BUY 6 166.35 =========================== ======================== BUY 3 166.35 =========================== ======================== BUY 4 166.48 =========================== ======================== SELL 7 166.35 =========================== ======================== SELL 11 166.35 =========================== ======================== SELL 35 166.35 =========================== ======================== SELL 3 166.62 =========================== ======================== (b) Derivatives transactions (other than options transactions) Product Nature of transaction Number of relevant Price per name, (Note 6) securities unit e.g. CFD (Note 7) (Note 5) (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name, selling, securities price e.g. American, date money paid/received e.g. call purchasing, to which European per unit option varying the option etc. (Note 5) etc. relates (Note 7) (ii) Exercising Product name, Number of securities Exercise price e.g. call option per unit (Note 5) (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 13(th) September 2019 Contact name Trish Mc Menamin ====================== Telephone number 3535717287 ====================== If a connected EFM, name of offeree/offeror with which connected ====================== If a connected EFM, state nature of connection (Note 10) ======================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEEAANDFSFNEFF
(END) Dow Jones Newswires
September 13, 2019 08:54 ET (12:54 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions